The British Association of Cancer Research (BACR), Royal Society of Medicine Oncology section and the Academy of Pharmaceutical Sciences of Great Britain (APSGB) are holding the second in a series of inter-disciplinary meetings on Thursday 27th November 2008.

This one-day meeting will be held in the Royal Society of Medicine, Wimpole Street London.

The aim of these meetings is to provide an opportunity to discuss issues relating to translational preclinical research and the challenges for transfer of agents into the clinic.

This meeting is to be on the role of model systems in informing the clinical and pre-clinical development of cancer drugs and drug/gene delivery systems, working through the challenges in taking targeted therapies forward to the clinic. Specifically we want to address the requirement for robust biomarkers in the development of targeted therapies and explore how informative current preclinical models are in taking these forward to the clinical setting. The day will begin with three introductory lectures exploring these issues from a clinical, academic and industrial perspective, followed by a panel discussion session. Following lunch there will be a poster session in which selected posters will be chosen for discussion. In the afternoon there will be presentations discussing more specific examples of the development of preclinical models to validate the use of biomarkers.

Cancer Immunotherapy: Regulatory Paradigms, Biomarkers/Clinical Endpoints, Technological Approaches

May 19th 2009, Royal Society of Medicine, London